Dow Up0.26% Nasdaq Down1.07%

Impax Laboratories Inc. (IPXL)

-NasdaqGS
24.15 0.01(0.04%) Sep 15, 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 188,121   118,718   100,741   132,641  
Cost of Revenue78,349  61,096  66,544  84,297  
Gross Profit 109,772   57,622   34,197   48,344  
Operating Expenses
Research Development21,252  21,741  17,638  16,071  
Selling General and Administrative32,817  25,477  29,327  27,968  
Non Recurring1,767  2,173  3,466  4,497  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 53,936   8,231   (16,234) (192)
Income from Continuing Operations
Total Other Income/Expenses Net396  464  440  262  
Earnings Before Interest And Taxes54,332  8,695  (15,794)70  
Interest Expense(93)65  41  50  
Income Before Tax54,425  8,630  (15,835)20  
Income Tax Expense19,354  2,205  (6,213)200  
Minority Interest -   -   -   -  
Net Income From Continuing Ops35,071  6,425  (9,622)(180)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 35,071   6,425   (9,622) (180)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 35,071   6,425   (9,622) (180)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.